Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)
| 24.62 Delayed Data As of 4:00pm ET |  -0.98 / -3.83%Today’s Change | 11.75 Today|||52-Week Range 27.10 | +11.76% Year-to-Date |
Latest DRNA News | Press Releases
No recent news for Dicerna Pharmaceuticals Inc.
Today’s Trading
| Previous close | 25.60 |
| Today’s open | 25.83 |
| Day’s range | 24.44 - 26.28 |
| Volume | 74,643 |
| Average volume (3 months) | 633,068 |
| Market cap | $1.8B |
Data as of 4:00pm ET, 01/27/2021
Growth & Valuation
| Earnings growth (last year) | -10.19% |
| Earnings growth (this year) | +37.15% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +287.05% |
| P/E ratio | NM |
| Price/Sales | 63.06 |
| Price/Book | 11.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NGMNGM Biopharmaceutica... | -1.51 | -5.69% |
| SRRKScholar Rock Holding... | -2.51 | -4.26% |
| REPLReplimune Group Inc | -0.25 | -0.63% |
| SGMOSangamo Therapeutics... | -0.34 | -2.36% |
Data as of 4:00pm ET, 01/27/2021
Financials
| Next reporting date | March 17, 2021 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $23.9M |
| Annual profit (last year) | -$120.5M |
| Net profit margin | -503.93% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Lexington, Massachusetts |
Forecasts
